Increased risk of organic erectile dysfunction in patients with chronic fatigue syndrome: a nationwide population-based cohort study.
Chao, C-H, Chen, H-J, Wang, H-Y et al. · Andrology · 2015 · DOI
Quick Summary
This study found that men with ME/CFS are nearly twice as likely to develop erectile dysfunction compared to men without ME/CFS. The risk was even higher in men with ME/CFS who did not have other health conditions like heart disease or diabetes, suggesting ME/CFS alone may play a significant role. The researchers tracked nearly 2,000 men with ME/CFS and compared them to over 7,900 healthy men over several years.
Why It Matters
This is one of the few studies documenting sexual dysfunction as a potential systemic complication of ME/CFS in men, expanding recognition of the disease's widespread effects beyond fatigue. Understanding these associations may help clinicians provide more comprehensive care and validate patient experiences of multisystem involvement in ME/CFS.
Observed Findings
Men with ME/CFS had 1.88-fold higher incidence of organic ED (3.23 vs. 1.73 per 1,000 person-years) compared to controls.
The adjusted hazard ratio for ED was highest (3.87) in ME/CFS patients with no other comorbidities, suggesting ME/CFS alone contributed substantially to ED risk.
ED incidence increased with age (≥40 years) in both CFS and non-CFS cohorts.
Combined presence of ME/CFS and comorbidities (cardiovascular disease, diabetes, kidney disease, depression, anxiety) showed synergistic effects on ED risk.
In non-CFS males, ED incidence rose as the number of comorbidities increased.
Inferred Conclusions
ME/CFS is independently associated with increased risk of organic erectile dysfunction, even in the absence of traditional comorbidities.
The stronger association in ME/CFS patients without comorbidities suggests disease-specific mechanisms (possibly autonomic dysfunction, inflammatory pathways, or mitochondrial dysfunction) may underlie sexual dysfunction.
Comorbid conditions amplify ED risk in both CFS and non-CFS populations, indicating overlapping pathophysiology.
Remaining Questions
What are the specific biological mechanisms linking ME/CFS to erectile dysfunction (e.g., autonomic dysfunction, endothelial dysfunction, mitochondrial impairment, or inflammatory markers)?
What This Study Does Not Prove
This study demonstrates association, not causation—it does not prove that ME/CFS directly causes erectile dysfunction. The retrospective design and reliance on insurance billing codes mean actual ME/CFS severity and diagnostic accuracy cannot be verified, and unmeasured factors (medication use, lifestyle, psychological stress) may contribute to the observed association.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Does ME/CFS disease severity, duration, or symptom subtype correlate with ED risk?
Are these findings generalizable to other populations outside Taiwan, and do they apply to different diagnostic criteria (CDC 1994, 2005; Canadian Consensus; ICC)?
Could medications used to treat ME/CFS symptoms confound the association with erectile dysfunction?